Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin Heavy Chain Like 17 (FTHL17)
- Target
- FTHL17
- Molecular classification
- Other (Ferritin-like protein; not a classic therapeutic protein class such as receptor, transporter, etc.), Iron-binding protein (but lacks classical ferroxidase activity), Pseudogene (in some contexts, as there are many pseudogenes in the ferritin gene family, but FTHL17 itself is a protein-coding gene)
01
Overview
Ferritin Heavy Chain Like 17 (FTHL17) is a protein-coding gene on the X chromosome encoding a ferritin heavy chain-like protein. Unlike canonical ferritin, FTHL17 protein lacks ferroxidase activity and exhibits partial nuclear localization. Primarily expressed in embryonic germ cells and some tumor types, FTHL17 has been postulated to play regulatory roles in cell differentiation and possibly gene expression networks. Multiple related pseudogenes exist, but "ferritin light chain pseudogene 17" is not an established or annotated entity in gene databases, and FTHL17 itself is distinct from ferritin light chain (FTL) and their corresponding pseudogenes.
- Other names
- Ferritin heavy chain-like 17FTHL17sometimes associated with Friedreich Ataxia 2 in disease linkage annotations
02
Mechanism of action
Not applicable, as there are no drugs targeting FTHL17, and its functional role is poorly defined
03
Biological functions
Partial iron bindingPotential regulatory function in embryonic cell differentiationNot involved in canonical iron storage or ferroxidase activity
04
Disease associations
Friedreich Ataxia 2 (association in database annotation; no direct causal role)Cardiomyopathy (association reported; mechanistic details unclear)Cancer (upregulated in certain tumor cells; possible regulatory roles)
Beyond the preview
Go deeper on Ferritin Heavy Chain Like 17 (FTHL17).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ferritin Heavy Chain Like 17 (FTHL17).